Skip to main content
main-content
Erschienen in: Endocrine 1/2022

04.08.2022 | Brief report

Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years

verfasst von: G. Vitellius, B. Donadille, B. Decoudier, A. Leroux, S. Deguelte, S. Barraud, J. Bertherat, B. Delemer

Erschienen in: Endocrine | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

The most frequent endocrine Carney complex manifestation is a bilateral primary pigmented nodular adrenocortical disease and bilateral adrenalectomy (BA) is therefore its main treatment. In this study, a 40 years follow-up of six members of the same family with heterozygous PRKAR1A germline mutation, is reported over two generations. The first cases, two sisters with severe hyperandrogenism and Cushing syndrome (CS) diagnosed in 1972 at age 14 and 25, were successfully treated with unilateral adrenalectomy (UA). Their two brothers were then diagnosed, one with a CS-related severe osteoporosis treated with BA and the other with CS treated with UA. The second generation was diagnosed with CS signs at 7 and 21 years of age and were treated with BA and UA respectively. Out of the four patients treated with UA, the only event possibly related to CS was spontaneous episode of pulmonary embolism, 30 years after surgery. Hormonal evaluation revealed either eucortisolism in one patient or partial adrenal deficiency in two and mild hypercortisolism in one patient. For the two patients with BA, one of them accidentally died. The second one, surprisingly, recovered progressively normal cortisol secretion and circadian variation. Steroid substitution was stopped 6 years after her surgery and we demonstrated by iodocholesterol scintigraphy the presence of bilateral adrenal remnants. In conclusion, our results of long term evolution of PPNAD patients show that UA in this subset of patients could be considered to treat CS.
Literatur
2.
Zurück zum Zitat S. Espiard, M.C. Vantyghem, G. Assié, C. Cardot-Bauters, G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stroër, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, MO. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up. J. Clin. Endocrinol. Metab. 105, (2020). https://​doi.​org/​10.​1210/​clinem/​dgaa002 S. Espiard, M.C. Vantyghem, G. Assié, C. Cardot-Bauters, G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stroër, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, MO. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up. J. Clin. Endocrinol. Metab. 105, (2020). https://​doi.​org/​10.​1210/​clinem/​dgaa002
3.
Zurück zum Zitat J. Bertherat, A. Horvath, L. Groussin, S. Grabar, S. Boikos, L. Cazabat, R. Libe, F. René-Corail, S. Stergiopoulos, I. Bourdeau, T. Bei, E. Clauser, A. Calender, L.S. Kirschner, X. Bertagna, J.A. Carney, C.A. Stratakis, Mutations in regulatory subunit type 1A of cyclic adenosine 5’-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085–2091 (2009). https://​doi.​org/​10.​1210/​jc.​2008-2333 CrossRefPubMedPubMedCentral J. Bertherat, A. Horvath, L. Groussin, S. Grabar, S. Boikos, L. Cazabat, R. Libe, F. René-Corail, S. Stergiopoulos, I. Bourdeau, T. Bei, E. Clauser, A. Calender, L.S. Kirschner, X. Bertagna, J.A. Carney, C.A. Stratakis, Mutations in regulatory subunit type 1A of cyclic adenosine 5’-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085–2091 (2009). https://​doi.​org/​10.​1210/​jc.​2008-2333 CrossRefPubMedPubMedCentral
6.
13.
Zurück zum Zitat D. Vezzosi, F. Tenenbaum, L. Cazabat, F. Tissier, M. Bienvenu, C.A. Carrasco, M. Laloi-Michelin, G. Barrande, H. Lefebvre, S. Hiéronimus, A. Tabarin, X. Bertagna, P. Legmann, M.C. Vantyghem, J. Bertherat, Hormonal, radiological, np-59 scintigraphy, and pathological correlations in patients with Cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 100, 4332–4338 (2015). https://​doi.​org/​10.​1210/​jc.​2015-2174 CrossRefPubMed D. Vezzosi, F. Tenenbaum, L. Cazabat, F. Tissier, M. Bienvenu, C.A. Carrasco, M. Laloi-Michelin, G. Barrande, H. Lefebvre, S. Hiéronimus, A. Tabarin, X. Bertagna, P. Legmann, M.C. Vantyghem, J. Bertherat, Hormonal, radiological, np-59 scintigraphy, and pathological correlations in patients with Cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 100, 4332–4338 (2015). https://​doi.​org/​10.​1210/​jc.​2015-2174 CrossRefPubMed
Metadaten
Titel
Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years
verfasst von
G. Vitellius
B. Donadille
B. Decoudier
A. Leroux
S. Deguelte
S. Barraud
J. Bertherat
B. Delemer
Publikationsdatum
04.08.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03142-4

Weitere Artikel der Ausgabe 1/2022

Endocrine 1/2022 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.